Corcept Therapeutics (CORT) Current Leases (2019 - 2026)

Corcept Therapeutics has reported Current Leases for 8 years, with the latest figure at $1.9 million in Q2 2026.

• Quarterly Current Leases rose 88.5% year-over-year to $1.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.9 million (up 88.5% YoY) and the FY2025 annual result came in at $1.1 million, up 30.76% from the prior year.
• Current Leases improved to $1.9 million in Q2 2026 per CORT's latest filing, from $1.6 million in the prior quarter.
• Over five years, Current Leases peaked at $2.3 million in Q1 2022 and troughed at $44000.0 in Q2 2024.
• A 5-year average of $982555.6 and a median of $1.0 million in 2025 frame the typical range for Current Leases.
• The sharpest annual moves came in 2023 and 2025: Current Leases tumbled 86.88% in 2023, then surged 2211.36% in 2025.
• Over 5 years, Current Leases stood at $1.1 million in 2022, then sank by 86.79% to $151000.0 in 2023, then soared by 449.01% to $829000.0 in 2024, then soared by 30.76% to $1.1 million in 2025, then surged by 76.85% to $1.9 million in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $1.9 million, $1.6 million, and $1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.